Matthieu Pelletier-Galarneau, MD MSc
5 clinical trials · Sponsor
◉ Watch Matthieu Pelletier-Galarneau, MD MSc
| Record | Firm | Date |
|---|---|---|
| Parathyroid Adenoma Detection With Rubidium-82 Imaging (NCT07099404) | Matthieu Pelletier-Galarneau, MD MSc | 2025-11-01 |
| In Vivo Quantitative Mapping of Mitochondrial Cardiac Membrane Potential in Heart Failure (NCT07087210) | Matthieu Pelletier-Galarneau, MD MSc | 2024-11-25 |
| Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging (NCT06350903) | Matthieu Pelletier-Galarneau, MD MSc | 2024-06-01 |
| Assessment of Renal Microcirculation With Rubidium Positron Emission Tomography (NCT06332456) | Matthieu Pelletier-Galarneau, MD MSc | 2023-07-04 |
| Effect of a Single Ultra-Processed Meal on Myocardial Endothelial Function Assessed With Positron Emission Tomography (NCT06353009) | Matthieu Pelletier-Galarneau, MD MSc | 2020-08-20 |
Track Matthieu Pelletier-Galarneau, MD MSc automatically
Every clearance here is in the API, with alerts when new ones post.